Michael Raab
Director; Director, President & CEO · 12 filings · Latest: Aug 21, 2026
AMICUS THERAPEUTICS, INC.
ARDELYX, INC.
Tempest Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARDX | Michael Raab | Director, President & CEO | Aug 21, 2026 | Sale | $3.86 | 58,574 | $225.9K | 1,619,792 | |
ARDX | RAAB MICHAEL | — | Aug 21, 2026 | Proposed Sale | $4.03 | 44,500 | $179.3K | — | |
ARDX | Michael Raab | Director, President & CEO | Jul 15, 2026 | Sale | $5.06 | 41,668 | $210.9K | 1,678,366 | |
ARDX | Michael Raab | Director, President & CEO | Jul 15, 2026 | Option Exercise | $0.99 | 20,834 | $20.6K | 1,720,034 | |
ARDX | Michael Raab | Director, President & CEO | Jun 15, 2026 | Sale | $5.67 | 41,666 | $236.3K | 1,699,200 | |
ARDX | Michael Raab | Director, President & CEO | Jun 15, 2026 | Option Exercise | $0.99 | 20,833 | $20.6K | 1,740,866 | |
ARDX | RAAB MICHAEL | — | Jun 15, 2026 | Proposed Sale | $5.68 | 41,666 | $236.7K | — | Jun 17 8:00 PM 144/A |
ARDX | MICHAEL RAAB | — | Jun 15, 2026 | Proposed Sale | $5.69 | 125,000 | $711.3K | — | |
ARDX | Michael Raab | Director, President & CEO | May 21, 2026 | Sale | $6.27 | 54,748 | $343.1K | 1,720,033 | |
ARDX | RAAB MICHAEL | — | May 19, 2026 | Proposed Sale | $6.23 | 44,500 | $277.2K | — | |
ARDX | Michael Raab | Director, President & CEO | May 15, 2026 | Sale | $6.28 | 41,666 | $261.6K | 1,774,781 | |
ARDX | Michael Raab | Director, President & CEO | May 15, 2026 | Option Exercise | $0.99 | 20,833 | $20.6K | 1,816,447 | |
ARDX | Michael Raab | Director, President & CEO | Apr 15, 2026 | Sale | $6.29 | 41,668 | $262.0K | 1,795,614 | |
ARDX | Michael Raab | Director, President & CEO | Apr 15, 2026 | Option Exercise | $0.99 | 20,834 | $20.6K | 1,837,282 | |
ARDX | Michael Raab | Director, President & CEO | Mar 16, 2026 | Sale | $5.84 | 41,666 | $243.3K | 1,816,448 | |
ARDX | Michael Raab | Director, President & CEO | Mar 16, 2026 | Option Exercise | $0.99 | 20,833 | $20.6K | 1,856,986 | |
ARDX | Michael Raab | Director, President & CEO | Feb 24, 2026 | Sale | $6.26 | 41,666 | $260.6K | 1,836,153 | |
ARDX | Michael Raab | Director, President & CEO | Feb 24, 2026 | Option Exercise | $0.99 | 20,833 | $20.6K | 1,877,819 | |
ARDX | MICHAEL RAAB | — | Feb 24, 2026 | Proposed Sale | $5.75 | 166,666 | $958.3K | — | |
ARDX | Michael Raab | Director, President & CEO | Feb 20, 2026 | Sale | $5.85 | 45,982 | $268.8K | 1,856,986 |
Page 1 of 2
Next →